Abingworth

Get funding

Abingworth works with entrepreneurs to turn breakthrough science into breakthrough medicine.

Use:
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 582M €
Entity type: Private Equity Firm
Vertical focus: All
Website: https://www.abingworth.com/

Status:
Open
Funding type: Equity investment;
Geographic focus:
Public/Private: Private
Stage focus: Seed;
Applicant target: Startup;

Add a Review Send question

Overview

Since their first biotech investment over thirty years ago, Abingworth has helped young biopharma companies on both sides of the Atlantic turn the latest scientific discoveries into dozens of new treatments for patients.

Abingworth has raised 14 funds dedicated to investing in life sciences and healthcare.
Their two most recent, Abingworth Bioventures 8 and Abingworth Clinical Co-Development Fund 2, raised $466 million and $583 million respectively and are actively investing.

The funds invest in private and public companies across three broad strategic areas: seed and early stage, development stage (including VIPEs and public markets) and clinical co-development.

Portfolio: Ascend, Exicure, Glycomine, IFMthera.

Last updated on 2023-05-17 11:03